Ukuhlolwa Komtholampilo Kufeza Inombolo Ehlosiwe Yeziguli Zokufunda Ngesifo I-Alzheimer's

A BAMBA MahhalaRelease 3 | eTurboNews | eTN
Isithombe sikaLinda Hohnholz
Ibhalwe ngu Linda Hohnholz

I-Synaptogenix, Inc. namuhla imemezele ukuthi isiqedile ukubhalisa inhloso yayo yeziguli eziyi-100 ezifundweni zayo eziqhubekayo zeNational Institutes of Health (“NIH”) ezixhaswe ngeSigaba 2b socwaningo lomtholampilo lwe-Bryostatin-1 ezigulini ezinesifo i-Alzheimer's esithuthuke futhi esibi kakhulu (“AD ”). Inkampani ilindele ukumemezela idatha ephezulu evela ocwaningweni ngekota yesine ka-2022.

I-Synaptogenix iphinda ibike ukuthi i-Data Safety Monitoring Board ezimele (“DSMB”) eyengamele isilingo iqinisekise ukungabikho kwanoma yiziphi izinkinga zokuphepha ezimbi ezihlobene nezidakamizwa.

I-Bryostatin-1 idale ukuthuthukiswa okukhulu kwengqondo (i-4.0 SIB psychometric score ngenhla kwesisekelo) ezigulini ezishiwo ngaphambili ezathola i-Bryostatin-1 engekho i-Namenda ezivivinyweni zethu ezimbili ezedlule, ezihlanganisiwe zezinyanga ezi-3, ezisanda kushicilelwa kontanga- i-athikili ebuyekeziwe (i-JAD, 2022) - kuyilapho iziguli ezilashwe nge-Placebo zingabonisi nzuzo enkulu. Ukwelashwa kwe-Bryostatin-1 manje sekunwetshiwe ukuze kufake inani eliphindwe kabili lemithamo (N = 14) ocwaningweni lwamanje lwezinyanga eziyisi-6, olulawulwa yi-placebo, lapho ukubhaliswa okungahleliwe kuye kwalawulwa ngokucophelela ukuze kutholwe izisekelo ezilinganiselwe ekwelapheni kanye namaqoqo e-placebo. Iziguli zizobe ziqashelwe isikhathi esingangezinyanga ezintathu ngemva kokuyeka ukudosa, uma kubhekwa ukuphikelela kwenzuzo okungenani izinsuku ezingama-30 ngemva komthamo owawuphawulwe ngaphambilini.

“Siyakhuthazwa ukuthi idatha yomugqa ophezulu okumele iqoqwe ngekota yesi-4, 2022, izobonisa inzuzo efanayo noma enkulu esivele ibonwe ezigulini ezikumaqembu afanayo, aphathwe ngaphambilini ayeshiwo ngaphambili ezivivinyweni zethu zokulinga zeSigaba 2a zangaphambilini. Ukungabi bikho kwanoma yiziphi izehlakalo ezimbi ezihlobene nezidakamizwa, njengoba kuye kwaphawulwa ngamanye amasu ambalwa okwelapha afinyelela ekugunyazweni okulinganiselwe kwe-Food and Drug Administration (“FDA”) ye-AD, kufanele kusize izinyathelo zethu ezilandelanayo eziya ekusetshenzisweni komtholampilo. Izinzuzo okungenani zamaphuzu angu-4.0 SIB, ngenhla kwesisekelo, zingaba nenjongo ngokomtholampilo, ngakho-ke zinamandla okwelapha isifo esiwumsuka kanye nokunikeza ukukhululeka kwezimpawu,” kusho uDaniel Alkon, MD, uMongameli Wenkampani kanye Nesikhulu Esiyinhloko Sezesayensi. .

U-Alan Tuchman MD, Isikhulu Esiphezulu Senkampani, uthe, “Ubufakazi buyakhula futhi buyaqhubeka nokusekela i-Bryostatin-1 njengendlela yokwelapha engase ibe khona yesifo i-Alzheimer's. Sijabule namuhla ukumemezela ukuqedwa kokubhaliswa kwethu kweSigaba 2b futhi silindele ngabomvu ukufundwa kwedatha yethu ephezulu ngasekupheleni kwalo nyaka.”

Mayelana umbhali

Isithombe sikaLinda Hohnholz

Linda Hohnholz

Umhleli omkhulu we eTurboNews ezinze eTN HQ.

Bhalisa
Yazisa ngakho
isivakashi
0 Amazwana
Okungaphakathi Okuphakelayo
Buka wonke amazwana
0
Ungathanda imibono yakho, ngicela uphawule.x
Yabelana ku...